N. Veyrenche

Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift β-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2]

P. Joly, P. Connes, P. Lacan, 2017, Hemoglobin.

Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19

M. Picot, P. Van de Perre, A. Bourdin, 2020, The Journal of infectious diseases.

Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19

M. Picot, P. Van de Perre, A. Bourdin, 2020, medRxiv.

Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents

M. Picot, D. Muriaux, P. Van de Perre, 2021, Scientific Reports.

Diagnosis value of SARS‐CoV‐2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission

P. Van de Perre, V. Foulongne, M. Segondy, 2020, medRxiv.

SARS-CoV-2 nucleocapsid urine antigen in hospitalized patients with Covid-19

P. Van de Perre, V. Le Moing, E. Tuaillon, 2022, The Journal of infectious diseases.

SARS-CoV-2 nucleocaspid antigen in urine of hospitalized patients with Covid-19

P. Van de Perre, V. Le Moing, E. Tuaillon, 2021, medRxiv.

Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs

J. Routy, P. Van de Perre, F. Mennechet, 2022, Frontiers in Immunology.